F-1/A: Empro Group Inc Files for IPO to List on Nasdaq Capital Market

Empro Group Inc, a Cayman Islands-based beauty and healthcare company, is seeking to raise capital through an initial public offering (IPO) to list its ordinary shares on the Nasdaq Capital Market under the ticker EMPG.

Summary

• Empro Group Inc, a Cayman Islands company with operations in Malaysia, has filed for an IPO to list on the Nasdaq Capital Market.
• The company expects the initial public offering price to be in the range of $4.00 to $4.50 per share.
• The company is offering 1,250,000 Ordinary Shares.
• The company has reserved the symbol EMPG for its Nasdaq listing.
• The company's founder, Yeoh Chee Wei, is expected to own approximately 64.7% of the outstanding Ordinary Shares after the offering.
• The company's revenue for the fiscal year ended December 31, 2024, was approximately $5.48 million with a net profit of approximately $0.75 million.
• The company intends to use the proceeds from the offering for working capital, market penetration and development, operating expenses and transaction expenses.
• The company's business is operated through its wholly-owned Malaysian subsidiary, EMP Solution Sdn. Bhd.

Sentiment

Score: 7

Explanation: The document presents a generally positive outlook, highlighting revenue growth and profitability, but also acknowledges risks and challenges associated with the business and industry.

Positives

• The company has a rich brand history spanning over 19 years.
• The company has a track record of consistently delivering safe, efficacious and innovative beauty and healthcare products.
• The company has developed strong relationships with partners, regulators and government agencies.
• The company boasts a robust and experienced management team.
• The company's revenue diversification following the introduction of new products in its beauty segment enhances its financial resilience.
• The company's marketing strategy is adaptable, designed to evolve in response to local market dynamics.
• The company's total revenue increased by $1,787,941, or 48.37%, to $5,484,664 for the fiscal year ended December 31, 2024.
• The company had a net profit of approximately $0.75 million for the fiscal year ended December 31, 2024.

Negatives

• The company operates in a dynamic healthcare and beauty industry and has a limited operating history.
• The healthcare industry and the beauty industry are highly competitive.
• The company's total revenue, and the revenue generated by its healthcare business segment, decreased considerably during the 2023 fiscal year due to a marked reduction in COVID-19 cases.
• The company may not be able to maintain profitability in the future.
• The company relies on third-party e-commerce platforms to sell its products online.
• The company relies on a limited number of ODM/OEM and packaging supply partners to produce its products.
• The company is controlled by a single shareholder, whose interest in its business may be different than yours.

Risks

• The company's historical results of operations and financial performance may not be indicative of future performance.
• The company's success is dependent on the continued popularity of its healthcare and beauty products and its ability to anticipate and respond to changes in the healthcare and beauty industry trends and consumer preferences and behavior in a timely manner.
• The company's new product introductions may not be as successful as it anticipates, which could have a material adverse effect on its business, prospects, financial condition, and results of operations.
• The company may be unable to manage its growth effectively or efficiently.
• The sale of counterfeit product may affect the company's reputation and profitability.
• The company's operating results could be materially harmed if it is unable to accurately forecast consumer demand for its products or adequately manage its inventory.
• The market for beauty products in Malaysia and Southeast Asia is continuously evolving and may not grow as quickly as expected, or at all, which could negatively affect the company's business and prospects.
• The company may be subject to infringement claims of intellectual property rights or other rights of third parties, which may be expensive to defend and may disrupt the company's business and operations.
• The company may not have sufficient funds to satisfy indemnification claims of its directors and officers.
• There has been no public market for the company's Ordinary Shares prior to this offering, and you may not be able to resell our Ordinary Shares at or above the price you pay for them, or at all.

Future Outlook

The company intends to develop its business and strengthen brand loyalty by expanding its product offerings, expanding into new markets and territories within ASEAN and Europe, and investing in new technologies.

Industry Context

The beauty and healthcare industries are highly competitive, with Empro Group facing competition from both national and international entities. The company's success depends on its ability to adapt to changing market trends and consumer preferences.

Comparison to Industry Standards

• The document does not provide enough information to make a detailed comparison to industry standards.
• However, the document mentions Watsons and Sasa as distribution partners, which are leading retailers in the ASEAN region.
• The document also mentions that the company's products are sold in 15 Asian, European and Middle-East markets, which indicates a global presence.

Related Party Transactions

• The company has related party transactions with Jingga Anggun Sdn Bhd, Mosfac Sdn Bhd, Mimo Motor Sdn Bhd, Emptech Upcycle Sdn Bhd and Brand Multi Plus Sdn Bhd.
• These transactions include purchases, sales, and outstanding receivables and payables.

Stakeholder Impact

• The IPO will provide the company with additional capital to fund its growth strategies, which could benefit shareholders, employees, and customers.
• The company's expansion into new markets could create new job opportunities.
• The company's commitment to quality and innovation could benefit customers by providing them with better products and services.

Next Steps

• The company intends to use the proceeds from the offering for working capital, market penetration and development, operating expenses and transaction expenses.
• The company plans to expand its product offerings, expand into new markets and territories within ASEAN and Europe, and invest in new technologies.

Key Dates

Keywords

IPO, initial public offering, beauty, healthcare, cosmetics, skincare, EMPRO, Nasdaq, EMPG, Malaysia, ASEAN